These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1573505)

  • 1. The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children.
    Gouyon JB
    J Pediatr Gastroenterol Nutr; 1992 Jan; 14(1):120. PubMed ID: 1573505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiotoxicity of intravenous erythromycin lactobionate in the neonatal period].
    Gouyon JB; Betremieux T; Petion AM; Beneton C; Bavoux F
    Arch Fr Pediatr; 1991 May; 48(5):375-6. PubMed ID: 1859247
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of erythromycin for postpyloric placement of feeding tubes in critically ill children: a randomized, double-blind, placebo controlled study.
    Gharpure V; Meert KL; Sarnaik AP
    JPEN J Parenter Enteral Nutr; 2001; 25(3):160-5. PubMed ID: 11334066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous erythromycin for postpyloric intubation.
    Di Lorenzo C; Lachman R; Hyman PE
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):45-7. PubMed ID: 2136585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature.
    Farrar HC; Walsh-Sukys MC; Kyllonen K; Blumer JL
    Pediatr Infect Dis J; 1993 Aug; 12(8):688-91. PubMed ID: 8018130
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimal method of postpyloric tube placement still unclear.
    Hallstrom CK; Jacobs BR
    Crit Care Med; 2003 Jan; 31(1):315-6. PubMed ID: 12545040
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peroperative circulatory arrest after intravenous injection of erythromycin lactobionate].
    Hummel JC; Haberer JP
    Ann Fr Anesth Reanim; 1988; 7(1):85-6. PubMed ID: 3348523
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants.
    Gouyon JB; Benoit A; Bétremieux P; Sandre D; Sgro C; Bavoux F; Beneton C; Badoual J
    Pediatr Infect Dis J; 1994 Sep; 13(9):840-1. PubMed ID: 7808866
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of intravenous erythromycin lactobionate in respiratory infections.
    Di Sciacca A; Durante F; Cucchiara G; Ingrassia A; Mira G; Mannone F; Di Piazza RM; Frontini A; Barbagallo Sangiorgi G
    J Int Med Res; 1987; 15(4):245-50. PubMed ID: 3653502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible risk for cardiac arrhythmia related to intravenous erythromycin.
    Haefeli WE; Schoenenberger RA; Weiss P; Ritz R
    Intensive Care Med; 1992; 18(8):469-73. PubMed ID: 1289371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedside Placement of the Postpyloric Tube in Infants.
    Clifford P; Ely E; Heimall L
    Adv Neonatal Care; 2017 Feb; 17(1):19-26. PubMed ID: 27902503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous erythromycin lactobionate-induced severe nausea and vomiting.
    Seifert CF; Swaney RJ; Bellanger-McCleery RA
    DICP; 1989 Jan; 23(1):40-4. PubMed ID: 2655295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulminant hepatic failure associated with intravenous erythromycin lactobionate.
    Gholson CF; Warren GH
    Arch Intern Med; 1990 Jan; 150(1):215-6. PubMed ID: 2297290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin lactobionate toxicity in preterm neonates.
    Sims PJ; Waites KB; Crouse DT
    Pediatr Infect Dis J; 1994 Feb; 13(2):164-7. PubMed ID: 8190550
    [No Abstract]   [Full Text] [Related]  

  • 15. Bedside postpyloric placement of weighted feeding tubes.
    Ugo PJ; Mohler PA; Wilson GL
    Nutr Clin Pract; 1992 Dec; 7(6):284-7. PubMed ID: 1289702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indicators of postpyloric feeding tube placement in children.
    Gharpure V; Meert KL; Sarnaik AP; Metheny NA
    Crit Care Med; 2000 Aug; 28(8):2962-6. PubMed ID: 10966279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible sensorineural hearing loss with intravenous erythromycin lactobionate.
    Karmody CS; Weinstein L
    Ann Otol Rhinol Laryngol; 1977; 86(1 Pt 1):9-11. PubMed ID: 835977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac actions of erythromycin: influence of female sex.
    Drici MD; Knollmann BC; Wang WX; Woosley RL
    JAMA; 1998 Nov; 280(20):1774-6. PubMed ID: 9842954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transpyloric feeding tube placement in critically ill patients using electromyogram and erythromycin infusion.
    Levy H; Hayes J; Boivin M; Tomba T
    Chest; 2004 Feb; 125(2):587-91. PubMed ID: 14769742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-effects due to the intravenous infusion of erythromycin lactobionate.
    Putzi R; Blaser J; Lüthy R; Wehrli R; Siegenthaler W
    Infection; 1983; 11(3):161-3. PubMed ID: 6885176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.